CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,736,806 | -51.1% | 148,572 | -43.8% | 0.00% | -100.0% |
Q2 2023 | $3,553,186 | -50.6% | 264,374 | -39.1% | 0.00% | -50.0% |
Q1 2023 | $7,192,421 | -22.8% | 433,801 | -13.4% | 0.00% | 0.0% |
Q4 2022 | $9,314,415 | +186.3% | 500,775 | +97.5% | 0.00% | +100.0% |
Q3 2022 | $3,253,000 | +678.2% | 253,530 | +325.5% | 0.00% | – |
Q2 2022 | $418,000 | -54.8% | 59,591 | -46.6% | 0.00% | – |
Q1 2022 | $924,000 | -59.3% | 111,510 | -66.7% | 0.00% | – |
Q4 2021 | $2,268,000 | +83.6% | 334,902 | +43.7% | 0.00% | – |
Q3 2021 | $1,235,000 | -58.8% | 233,110 | -55.2% | 0.00% | – |
Q2 2021 | $2,996,000 | +226.0% | 520,806 | +161.3% | 0.00% | – |
Q1 2021 | $919,000 | -9.0% | 199,280 | -34.3% | 0.00% | – |
Q4 2020 | $1,010,000 | +18.8% | 303,092 | +5.9% | 0.00% | – |
Q3 2020 | $850,000 | +28.2% | 286,301 | +99.5% | 0.00% | – |
Q2 2020 | $663,000 | -36.6% | 143,531 | -47.2% | 0.00% | – |
Q1 2020 | $1,046,000 | +33.9% | 271,710 | +30.5% | 0.00% | – |
Q4 2019 | $781,000 | -65.0% | 208,263 | -50.5% | 0.00% | -100.0% |
Q3 2019 | $2,233,000 | -66.1% | 420,434 | -75.5% | 0.00% | – |
Q2 2019 | $6,585,000 | +526.5% | 1,714,174 | +731.7% | 0.00% | – |
Q1 2019 | $1,051,000 | +783.2% | 206,100 | +232.0% | 0.00% | – |
Q4 2018 | $119,000 | -88.0% | 62,078 | -76.4% | 0.00% | – |
Q3 2018 | $995,000 | +233.9% | 263,300 | +176.3% | 0.00% | – |
Q2 2018 | $298,000 | +136.5% | 95,295 | +80.8% | 0.00% | – |
Q1 2018 | $126,000 | -57.7% | 52,700 | -30.8% | 0.00% | – |
Q4 2017 | $298,000 | +204.1% | 76,194 | +97.4% | 0.00% | – |
Q3 2017 | $98,000 | -76.0% | 38,600 | -74.0% | 0.00% | – |
Q2 2017 | $409,000 | +549.2% | 148,200 | +148.9% | 0.00% | – |
Q4 2016 | $63,000 | -28.4% | 59,541 | -26.0% | 0.00% | – |
Q3 2016 | $88,000 | +10.0% | 80,497 | -28.3% | 0.00% | – |
Q2 2016 | $80,000 | +110.5% | 112,310 | +252.8% | 0.00% | – |
Q1 2016 | $38,000 | -39.7% | 31,830 | +23.4% | 0.00% | – |
Q4 2015 | $63,000 | -11.3% | 25,789 | +9.6% | 0.00% | – |
Q3 2015 | $71,000 | -82.2% | 23,523 | -75.7% | 0.00% | – |
Q2 2015 | $400,000 | -74.3% | 96,694 | -73.1% | 0.00% | -100.0% |
Q1 2015 | $1,556,000 | +681.9% | 359,254 | +437.3% | 0.00% | – |
Q4 2014 | $199,000 | -8.7% | 66,857 | +2.1% | 0.00% | – |
Q3 2014 | $218,000 | -37.2% | 65,495 | -52.2% | 0.00% | – |
Q2 2014 | $347,000 | – | 137,033 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |